What are the clinical presentation and treatment options for Bartonella Quintana infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bartonella quintana infection presents with symptoms including relapsing fever, headache, bone pain, and a maculopapular rash, and treatment typically involves doxycycline 100mg twice daily for 4-6 weeks, with alternative antibiotics and extended treatment durations considered in certain cases. The clinical presentation of Bartonella quintana infection, also known as trench fever, includes a range of symptoms such as:

  • Relapsing fever
  • Headache
  • Bone pain, particularly in the shins
  • Maculopapular rash Patients may also experience prolonged bacteremia, endocarditis, and bacillary angiomatosis (vascular proliferative lesions of the skin) 1.

Treatment Options

Treatment options for Bartonella quintana infection include:

  • Doxycycline 100mg twice daily for 4-6 weeks, which is effective against the intracellular bacteria
  • Combination therapy with gentamicin (3mg/kg/day divided into 2-3 doses) for the first 2 weeks along with doxycycline for a total of 6 weeks for severe infections or endocarditis
  • Alternative antibiotics such as azithromycin, erythromycin, or fluoroquinolones for patients who cannot tolerate doxycycline
  • Extended treatment duration of at least 3 months for immunocompromised patients with bacillary angiomatosis

Diagnosis and Prevention

Diagnosis of Bartonella quintana infection requires blood cultures using special techniques (lysis-centrifugation or prolonged incubation) as the bacteria is fastidious and slow-growing. The infection is transmitted by body lice and is more common in homeless populations and those with poor hygiene conditions, so addressing these underlying factors is essential for prevention of reinfection. Long-term suppression of infection with erythromycin or doxycycline should be considered in cases of relapse or reinfection 1.

From the Research

Clinical Presentation of Bartonella Quintana Infection

  • The clinical manifestations of Bartonella quintana infection can range from asymptomatic to severe and life-threatening disease 2, 3.
  • Common clinical presentations include:
    • Relapsing febrile illness
    • Headache
    • Leg pain
    • "Culture-negative" endocarditis
    • Bacillary angiomatosis, particularly in human immunodeficiency virus-infected persons 2, 3.
  • The severity of the infection correlates with the patient's immune status, with more severe disease occurring in immunocompromised individuals 4.

Treatment Options for Bartonella Quintana Infection

  • The treatment of Bartonella quintana infection typically involves the use of antibiotics, with the specific regimen depending on the severity and nature of the infection 2, 3, 5.
  • Recommended treatment options include:
    • Doxycycline
    • Erythromycin
    • Azithromycin
    • Gentamicin (in combination with doxycycline for endocarditis) 2, 5.
  • The duration of treatment can vary, but typically ranges from 4-6 weeks for uncomplicated bacteremia to 4-6 months for endocarditis 2.
  • Aminoglycosides, such as gentamicin, have been shown to be bactericidal against Bartonella species and are recommended for treatment of severe infections 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bartonella quintana and urban trench fever.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000

Research

Bartonella (Rochalimaea) quintana infections.

Clinical microbiology reviews, 1996

Research

Pathogenicity and treatment of Bartonella infections.

International journal of antimicrobial agents, 2014

Research

Current knowledge of Bartonella species.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.